- Generic name
- Glimepiride
- Strength
- 1 mg
- Dosage form
- Tablet
- Manufactured by
- Ad-din Pharmaceuticals Ltd.
Glaryl 1 Tablet
About Glaryl 1 Tablet
Glaryl 1 1 mg tablet is a medicine made by Ad-din Pharmaceuticals Ltd. Glaryl 1 1 mg tablet is used to lower blood sugar in adults with type II diabetes when diet and exercise alone do not keep glucose under control.
There are 41 brands of Glimepiride listed in Bangladesh. The lowest listed price is Mepid 1 mg Tablet at ৳ 2.51 per unit.
What is Glaryl 1 Tablet?
Glaryl 1 is a tablet from Ad-din Pharmaceuticals Ltd., with the generic name Glimepiride. Glaryl 1 1 mg tablet is a sulfonylurea antidiabetic medicine. Its active ingredient is Glimepiride, which belongs to the sulfonylurea group. Your doctor will decide whether it is suitable for you and will set the dose and course with regular blood sugar checks.
Uses of Glaryl 1
Glaryl 1 1 mg tablet is used to lower blood sugar in adults with type II diabetes when diet and exercise alone do not keep glucose under control. It may also be used together with metformin when diet, exercise and either medicine alone do not give adequate control. Your doctor will decide whether it suits your condition.
How to use Glaryl 1
Regular monitoring of blood and urine glucose helps detect whether the treatment is working or failing. Swallow the tablet with water. Glaryl 1 is taken by mouth. Take Glaryl 1 tablet exactly as your doctor prescribes. Tell your doctor about all other medicines you take, because some medicines can change how Glimepiride works. Do not change the dose yourself or stop the medicine without speaking to your doctor.
Side effects of Glaryl 1
Low blood sugar can cause symptoms such as sweating, shakiness, or confusion. Call your doctor promptly if these occur or if you feel unwell. Report any side effects to your doctor or pharmacist. Tell your doctor if you notice any of these, and seek help quickly for signs of low blood sugar. Tell your doctor if any side effect bothers you or does not go away.
Safety and precautions
The risk of low blood sugar can be higher in the first weeks, so careful monitoring is needed. Glaryl 1 1 mg tablet must not be used in type I diabetes, diabetic ketoacidosis or diabetic coma, or by people allergic to Glimepiride, other sulfonylureas or other sulfonamides. Ask your doctor or pharmacist before starting.
Frequently asked questions
What does Glaryl 1 treat?
Glaryl 1 1 mg tablet is used to lower blood sugar in adults with type II diabetes when diet and exercise alone do not keep glucose under control. It may also be used together with metformin when diet, exercise and either medicine alone do not give adequate control.
How do I use Glaryl 1 correctly?
Regular monitoring of blood and urine glucose helps detect whether the treatment is working or failing. Swallow the tablet with water.
What should I watch for while using Glaryl 1?
Low blood sugar can cause symptoms such as sweating, shakiness, or confusion. Call your doctor promptly if these occur or if you feel unwell.
Is Glaryl 1 safe for everyone?
The risk of low blood sugar can be higher in the first weeks, so careful monitoring is needed. Glaryl 1 1 mg tablet must not be used in type I diabetes, diabetic ketoacidosis or diabetic coma, or by people allergic to Glimepiride, other sulfonylureas or other sulfonamides.
Indications
- Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
- Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control. ... Read more
- Glimepiride is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
- Glimepiride may be used concomitantly with metformin when diet, exercise, and Glimepiride or metformin alone does not result in adequate glycaemic control.
- Glimepiride is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.
- Combined use of Glimepiride and insulin may increase the potential for hypoglycaemia.
Pharmacology
Dosage & Administration
Initial dose and dose titration: the usual initial dose is 1 mg once daily, if necessary, the daily dose can be increased. Any increase can be based on regular blood sugar monitoring, and should be gradual, i.e., at intervals of 1 to 2 weeks, and carried out stepwise, as follows: 1 mg -> 2 mg -> 3 mg -> 4 mg -> 6 mg.
Dose in patients with well controlled diabetes: the usual dose range in patients with well controlled diabetes is 1 to 4 mg daily.
Distribution of doses: Timing and distribution of doses are decided by the physician, in consideration of the patient's current life-style. Normally, a single daily dose is sufficient. This should be taken immediately before a substantial breakfast or if none is taken immediately before the first main meal. It is very important not to skip meals after taking the drug.
Secondary dosage adjustment: As control of diabetes improves, sensitivity to insuiin increases; therefore, Glimepiride requirement may fall as treatment proceeds. To avoid hypoglycaemia, timely dose reduction or cessation of Glimepiride therapy must be considered. A dose adjustment must also be considered whenever the patient's weight or life-styie changes, or other factors arise which cause an increased susceptibility to hypo or hyperglycaemia.
Changeover from other oral antidiabetics to Glimepiride: There is no exact dosage relationship between Glimepiride and other oral blood sugar lowering agents. When substituting Glimepiride for other such agents, the initial daily dose is 1 mg; this applies even in changeover from maximum dose of other oral blood sugar lowering agents. Any dose increase should be in accordance with guideline given above in 'initial dose and dose titration'. Consideration must be given to the potency and duration of action of the previous blood sugar lowering agent. It may be necessary to interrupt treatment to avoid additive effects which would increase the risk of hypoglycaemia.
Interaction
In addition to insulin and other oral antidiabetic agents, drugs which may potentiate the hypoglycaemic action of Glimepiride include: ACE inhibitors, aminosalicylic acid, anabolic steroids and male sex hormones, azapropazone, chloramphenicol, ciofibrate, coumarin derivatives, cyclophosphamide, disopyramide, fenfluramine, fenyramidol, fibrates, fluconazole, fluoxetine, guanethidine, ifosfamide, MAO-inhibitors, miconazole, oxpentifylline (high dose parenteral), oxyphenbutazone, para-aminosalicylic acid, phenylbutazone, probenecid, quinolones, salicylates, sulphinpyrazone, sulfonamide antibiotics, tetracyclines, tritoqualine, trofosfamide.
Drugs which may attenuate the hypoglycaemic action of Glimepiride include:
- Acetazoiamide, barbiturates, calcium channel blockers, corticosteroids, diazoxide, diuretics, glucagon, isoniazid, laxatives, nicotinic acid (high doses), oestrogens, phenothiazines, phenytoin, progestagens, rifampicin, sympathomimetic agents, thyroid hormones.
- H2 receptor antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood-glucose-lowering effect.
- Concomitant treatment with a beta-receptor blocker, clonidine, guanethidine or reserpine may mask the warning symptoms of a hypoglycaemic attack.
- Acute and chronic aicohol intake may either potentiate or attenuate the activity of Glimepiride in an unpredictable fashion.
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Glimepiride
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.